Figure 3From: CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy Kaplan-Meier survival curves in the CD133+ (≥10% expression) colorectal cancer patients according to adjuvant therapy status. The patients with CD133+ CRC had a significantly shorter OS if they had not received adjuvant therapy (p=0.0001).Back to article page